Morii H - Search Results

1

History of vitamin D treatment of renal osteodystrophy.

Morii H, Ishimura E, Inoue T, Tabata T, Morita A, Nishii Y, Fukushima M. Morii H, et al. Am J Nephrol. 1997;17(3-4):382-6. doi: 10.1159/000169125. Am J Nephrol. 1997. PMID: 9189258

2

The effect of oral 1 alpha-hydroxycalciferol treatment on bone mineral density in hemodialysis patients.

Morita A, Tabata T, Inoue T, Nishizawa Y, Morii H. Morita A, et al. Among authors: morii h. Clin Nephrol. 1996 Dec;46(6):389-93. Clin Nephrol. 1996. PMID: 8982555

3

Management of calcium and bone abnormalities in hemodialysis patients.

Morii H, Inoue T, Nishijima T, Tomokuni T, Ishikawa T, Moriya K, Kawai N, Araki H, Horio M, Shigeoka T, Tani K, Yamaguchi T, Kubodera N. Morii H, et al. Semin Nephrol. 2004 Sep;24(5):446-8. doi: 10.1016/j.semnephrol.2004.06.016. Semin Nephrol. 2004. PMID: 15490408

4

A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.

Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Morita A, et al. Among authors: morii h. Clin Nephrol. 1992 Sep;38(3):154-7. Clin Nephrol. 1992. PMID: 1395169

5

Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.

Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Emoto M, et al. Among authors: morii h. Nephron. 1992;61(2):181-6. doi: 10.1159/000186868. Nephron. 1992. PMID: 1630543

6

Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.

Miki T, Nakatsuka K, Nishizawa Y, Emoto M, Morita A, Tabata T, Matsushita Y, Inoue T, Morii H. Miki T, et al. Among authors: morii h. Endocrinol Jpn. 1991 Oct;38(5):479-83. doi: 10.1507/endocrj1954.38.479. Endocrinol Jpn. 1991. PMID: 1843267 Free article.

7

Circulating bone Gla protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay.

Nakatsuka K, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H, Ogata E. Nakatsuka K, et al. Among authors: morii h. Contrib Nephrol. 1991;90:147-54. doi: 10.1159/000420137. Contrib Nephrol. 1991. PMID: 1959340

8

Decreased bone mineral density in diabetic patients on hemodialysis.

Nishitani H, Miki T, Morii H, Nishizawa Y, Ishimura E, Hagiwara S, Nakatsuka K, Yamakawa M. Nishitani H, et al. Among authors: morii h. Contrib Nephrol. 1991;90:223-7. doi: 10.1159/000420147. Contrib Nephrol. 1991. PMID: 1959351

9

Impaired vitamin D metabolism and response in spontaneously diabetic GK rats.

Ishimura E, Nishizawa Y, Koyama H, Shoji S, Inaba M, Morii H. Ishimura E, et al. Among authors: morii h. Miner Electrolyte Metab. 1995;21(1-3):205-10. Miner Electrolyte Metab. 1995. PMID: 7565451

10

Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.

Nishizawa Y, Shoji T, Emoto M, Kawasaki K, Konishi T, Tabata T, Inoue T, Morii H. Nishizawa Y, et al. Among authors: morii h. Clin Nephrol. 1995 Apr;43(4):268-77. Clin Nephrol. 1995. PMID: 7606882 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters